Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. Net Income 2015–2025
Rein Therapeutics Inc. annual/quarterly net income history and growth rate from 2015 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Rein Therapeutics Inc. net income for the quarter ending March 31, 2026 was -5.8 M, a 6.13% increase year-over-year.
- Rein Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -23.7 M, a 0.05% increase year-over-year.
- Rein Therapeutics Inc. annual net income for 2025 was -49.9 M, a 20.69% decrease from 2024.
- Rein Therapeutics Inc. annual net income for 2024 was -62.9 M, a 299.71% increase from 2023.
- Rein Therapeutics Inc. annual net income for 2023 was -15.7 M, a 42.43% decrease from 2022.
- Rein Therapeutics Inc. annual net income for 2022 was -27.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rein Therapeutics Inc. Net Income — FAQ
Rein Therapeutics Inc. (RNTX) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Rein Therapeutics Inc.'s net income?
Rein Therapeutics Inc. (RNTX) reported net income of -$50M for fiscal 2025.
Where can I see RNTX's net income history?
The chart and table above show Rein Therapeutics Inc.'s net income by year and by quarter, including the growth rate.